POSCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

POSITRON CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$1.70+0.15 (+9.68%)

Close on Oct 19, 2026

Market cap: $55.84M
P/E (TTM): –
Dividend yield: –

Dividends

Positron has not reported a dividend

No dividend per share appears in Positron's annual filings since fiscal 2009.

Where these numbers come from

Parsed from the XBRL in Positron's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-400041 reverse split on May 15, 2015
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is POSC.

Revenue growth-21.5% · median 38.7%

Gross margin-458.2% · median 63.6%

Operating margin-2275.1% · median -253.6%

Net margin-2297.8% · median -341.1%

Company	Revenue	Growth
HYPR	$16.54M	+53.2%
ADMT	$3.24M	-2.2%
GTHP	$650.00K	+450.8%
POSC	$461.45K	-21.5%
NXL	$217.16K	+24.2%
ITOC	–	–

Company

Exchange: OTC
Industry: Electromedical & Electrotherapeutic Apparatus
Fiscal year ends: December 31
Employees: 10
Auditor: Salberg & Company, P.A.
SEC CIK: 844985

Advertisement
300 × 250